By Ryan Davis ( July 30, 2012, 9:39 PM EDT) -- When a branded drug company is found to have listed a use code for a product that overstates the scope of a patent, courts cannot order specific changes the company must make to rectify the problem, the Federal Circuit held Monday in a ruling attorneys said clarified a recent U.S. Supreme Court decision....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.